Novel transcript, antisense to NACC2

This is a natural antisense transcript that overlaps with the NACC2 gene, and has been identified in the human genome primarily through transcriptomic analysis. Natural antisense transcripts (NATs) are typically non-coding RNAs that modulate gene expression of their corresponding sense gene via mechanisms such as RNA masking, transcriptional interference, chromatin modification, or guiding epigenetic marks like DNA methylation. Such regulation can result in alternations of splicing, transcriptional activity, or local chromatin structure[1][2][3]. This transcript is not currently known to be involved in disease, nor is it targeted by drugs or used as a biomarker. Its biological relevance is presumed to be regulatory, but has not been experimentally validated or structurally characterized.\n\nKey references:\nNatural antisense transcripts regulate gene expression through diverse mechanisms—RNA masking, transcription interference, chromatin modification, and epigenetic silencing—but are generally not considered therapeutic targets unless directly implicated in disease or drug response[1][2][3].\n\nNote:\nIf you require information for structured target databases (e.g., pharmacological or drug discovery use), this entry should be marked as \"not a target\" or flagged for further biological validation. If future research implicates NATs like this in disease or therapeutic response, classification may change.

Other names

NAT to NACC2antisense RNA overlapping NACC2NACC2 antisense transcriptENSG00000306375